Registration number: 10993082

BA Pharma Limited

Contents

Company Information	1
Balance Sheet	2 to 3

BA Pharma Limited

Company Information

Directors

Mr W Bashir Miss S Bashir Mr M Bashir

Registered office

245 Kingsbury Road London NW9 8UG

Accountants

Richlands Business Advisers Limited Chartered Accountants42-46 Station Road Edgware Middlesex HA8 7AB

BA Pharma Limited

(Registration number: 10993082)
Balance Sheet as at 31 August 2025

	2025 £	2024 £
Fixed assets	115,071	153,428
Current assets	401,396	286,911
Prepayments and accrued income	1,512	7,003
Creditors: Amounts falling due within one year	(166,051)	(137,900)
Net current assets	236,857	156,014
Total assets less current liabilities	351,928	309,442
Creditors: Amounts falling due after more than one year	(122,978)	(144,344)
Accruals and deferred income	(6,150)	(2,950)
	222,800	162,148
Capital and reserves	222,800	162,148

BA Pharma Limited

(Registration number: 10993082)
Balance Sheet as at 31 August 2025 (continued)

1	General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
245 Kingsbury Road
London
NW9 8UG
United Kingdom

These financial statements were authorised for issue by the Board on 29 May 2026.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2024 - 3).

For the financial year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 29 May 2026 and signed on its behalf by:
 

......................................... Mr W Bashir Director

......................................... Miss S Bashir Director